EUVIMEDEUVIMED entdecken
Crossref

Totarol‐1 Derivative Improves Neuronal Disability in Lead‐Induced In Vivo Zebrafish Model

G Akash, S Madesh, Karthikeyan Ramamurthy, Bharath Kumar Chagaleti, Ali Oubella, Yassine Laamari, Bader O Almutairi, Ki Choon Choi, Muthu Kumaradoss Kathiravan, S Vijaya Bharathi, S Karthick Raja Namasivayam iD, Aziz Auhmani und 1 weitere

Journal of Biochemical and Molecular Toxicology · 2026-03 · 40 (3)

DOI: 10.1002/jbt.70762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 25.02.2026. Verfasst von G Akash und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India. Hauptthemen laut MEDLINE: Neurons, Brain, Lead. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Ongoing Research Funding Program, King Saud University, Riyadh, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A worldwide environmental danger resulting from extensive pollution, lead (Pb) exposure has significant neurotoxic potential. Neurological disorders underscore the necessity for effective therapeutic approaches modified to particular conditions. To evaluate the potential advantages of brain neuroplasticity, this work tests Totarol‐1, a new synthetic derivative, in the adult zebrafish model. Lead causes notable behavioral impairments, including memory loss, as evaluated by the T‐tank test, and increased anxiety reactions, measured by the novel tank test, along with noticeably greater lead buildup in brain tissue. Moreover, lead exposure may alter biochemical tests, including catalase (CAT), superoxide dismutase (SOD), acetylcholinesterase (AChE), and lipid peroxidase (LPO). Key genes related to ferroptosis and neuroinflammation, including GPX4, CX43, TNF‐α, and IL‐1β, were identified as dysregulated through molecular gene analysis, in which GPX4A and CX43 showing marked changes, indicating either reduced levels of ferroptosis or restoration of neuronal gap junctions. Treatment with the Totarol‐1 derivative notably reduced lead accretion in the brain and altered behavioral impairments, biochemical markers, and gene expression. Furthermore, the immunochemistry of the brain was examined using an α‐synuclein protein in Parkinson's disease (PD). The clump of this protein in the lead exposure group indicated a neurological condition, and was decreased due to Totarol‐1 derivative therapy techniques against lead‐induced neurotoxicity models. This work reveals that lead treatment in the zebrafish brain causes deficits at various organisational levels, which were corrected by Totarol‐1 derivative, thereby improving brain neuronal disability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuronsBrainLeadAnimalsZebrafishDisease Models, Animal

Stichwörter der Autor:innen

leadneuronal disabilityneuroplasticityneurotoxicitytotarol‐1

Substanzen

Lead

Autor:innen und Institutionen

  • Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.
  • Toxicology and Pharmacology Laboratory, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.
  • Dr A. P. J. Abdul Kalam Research Lab, Department of Pharmaceutical Chemistry, SRM College of Pharmacy, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.
  • Laboratory of Organic and Physical Chemistry, Applied Bioorganic Chemistry Team, Faculty of Sciences, Ibnou Zohr University, Agadir, Morocco.
  • Laboratory of Computer Science and Interdisciplinary Physics (LIPI), Higher Normal School of Fez (ENS-Fes), Sidi Mohamed Ben Abdellah University, Fez, Morocco.
  • Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.

ORCID-Profile: S Karthick Raja Namasivayam

Förderung

  • Ongoing Research Funding Program, King Saud University, Riyadh, Saudi Arabia

Zitieren

APA

Akash, G., Madesh, S., Ramamurthy, K., Chagaleti, B. K., Oubella, A., Laamari, Y., Almutairi, B. O., Choi, K. C., Kathiravan, M. K., Bharathi, S. V., Namasivayam, S. K. R., Auhmani, A., & Arockiaraj, J. (2026). Totarol‐1 Derivative Improves Neuronal Disability in Lead‐Induced In Vivo Zebrafish Model. Journal of Biochemical and Molecular Toxicology, 40(3). https://doi.org/10.1002/jbt.70762

Vancouver

Akash G, Madesh S, Ramamurthy K, Chagaleti BK, Oubella A, Laamari Y, et al. Totarol‐1 Derivative Improves Neuronal Disability in Lead‐Induced In Vivo Zebrafish Model. Journal of Biochemical and Molecular Toxicology. 2026;40(3). doi:10.1002/jbt.70762

BibTeX
@article{Akash2026,
  author = {Akash, G and Madesh, S and Ramamurthy, Karthikeyan and Chagaleti, Bharath Kumar and Oubella, Ali and Laamari, Yassine and Almutairi, Bader O and Choi, Ki Choon and Kathiravan, Muthu Kumaradoss and Bharathi, S Vijaya and Namasivayam, S Karthick Raja and Auhmani, Aziz and Arockiaraj, Jesu},
  title = {Totarol‐1 Derivative Improves Neuronal Disability in Lead‐Induced In Vivo Zebrafish Model},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  volume = {40},
  number = {3},
  doi = {10.1002/jbt.70762}
}
Kostenlos starten →